Blockchain-based medical service integration platform Miss Block listed on Bithumb Won Market

0

 159 total views

[Blockchain Today Reporter Seung-won Jeong] On the 25th, MISBLOC, a blockchain-based medical service integration platform, will be listed on the Korean virtual asset exchange Bithumb won market.

At around 11 am on the 25th, Bithumb Korea announced the listing of MissBloc MSB tokens in the KRW market through its own community site, Bithumb Cafe.

Miss Block is a blockchain-based medical service platform that provides verified medical information to patients, hospitals, governments, and public institutions in today’s big data era, and builds an efficient medical service ecosystem that can satisfy all participants.

Early this year, Miss Block released its own application’Anapatok’ Android version and iOS version. Users can make reservations in real time on Anapatok, and in the future, they will be able to receive medical consultations through video and chat with professional medical staff registered in the app.

Miss Block is holding two airdrop events to commemorate the listing on the Bithumb won market. A total of 1.5 BTC will be differentially paid according to the contribution of external MSB token deposit during the event period. In addition, a total of 45,000 MSB tokens will be differentially paid according to the daily transaction amount and contribution for a total of 3 days from the 25th to the 27th 24 o’clock. For more information on the Miss Block airdrop event, please check the Bithumb Exchange announcement.

Mr. Do-hee Kim, CEO of MissBloc, said, “Miss Block was selected as an excellent project in the BTC open evaluation following listing on the Bithumb BTC market and even made it listed on the KRW market.” We will deliver medical information and services effectively.”

On the other hand, Miss Block was selected as a virtual asset with the best results in the 8th round of Bithumb’BTC Open’, which was held for 4 days from April 26 to 29.

[email protected]

Disclaimer:

Blockcast.cc does not endorse any content or product on this page. While we aim at providing you all important information that we could obtain, readers should do their own research before taking any actions related to the company and carry full responsibility for their decisions, nor can this article be considered as investment advice or recommendations. Every investment and trading move involves risk, you should conduct your own research when making a decision.